CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Sector valuations Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209.62 USD | +1.71% |
|
+7.87% | -11.33% |
Main competitors
| P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 33.32x | 2.729 | -1.05x | 3.22x | 12.9x | 16.21x | -.--% | 10.82B | ||
| 46.85x | 4.047 | 1.56x | 6.27x | 22.01x | 33.72x | +0.85% | 46.11B | ||
| 31.75x | 6.373 | 5.58x | 3.64x | 15.14x | 17.9x | -.--% | 44.59B | ||
| -114.05x | 132.87 | 3.66x | 15.38x | -263.03x | -193.38x | -.--% | 35.48B | ||
| 78.53x | 2.483 | -2.48x | 11.9x | 41.1x | 65.4x | +0.25% | 31.29B | ||
| -7.14x | 2.528 | 0.31x | 5.98x | -5.31x | -4.76x | -.--% | 26.15B | ||
| 32.27x | 2.480 | 1.24x | 3.2x | 14.82x | 15.94x | -.--% | 24.92B | ||
| 14.2x | 2.260 | 0.57x | 4.75x | 9.3x | 9.6x | -.--% | 15.63B | ||
| 66.89x | 5.463 | 4.64x | 10.41x | 29.72x | 32.93x | +0.40% | 12.75B | ||
| 31.86x | 12.00 | 1.05x | 5x | 24x | 25.8x | -.--% | 11.42B | ||
| 50.42x | 2.732 | -1.3x | 5.29x | 14.24x | 18.53x | -.--% | 10.13B | ||
| -13.31x | 4.999 | 1.32x | 3952.76x | -10.02x | -9.88x | -.--% | 7.71B | ||
| -11.62x | 9,669.68 | -0.27x | 9.83x | -12.03x | -11.45x | -.--% | 6.73B | ||
| 47.63x | 4.015 | 15.12x | 8.76x | 30.53x | 43.49x | +1.17% | 6.52B | ||
| 26.63x | 1.949 | -1.44x | 4.57x | 19.69x | 20.64x | +0.75% | 5.72B | ||
| -73x | 77.73 | 0.86x | 10.05x | -21.97x | -21.93x | -.--% | 5.76B | ||
| 20.97x | 2.704 | 1.73x | 2.94x | 12.4x | 19.86x | +1.00% | 4.81B | ||
| 14.56x | 3.090 | -2.01x | 2.66x | 8.79x | 9.55x | -.--% | 4.67B | ||
| Average | 15.38x | 552.23 | 1.62x | 225.92x | -3.21x | 4.90x | +0.25% | 17.29B | |
| Weighted average by Cap. | 15.89x | 229.24 | 1.83x | 105.02x | -15.79x | -2.24x | +0.22% |
